FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Mayer

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jennifer A Chan; Nadine Jackson; Paige Malinowski; Robert J Mayer; Eileen Regan; Matthew H Kulke
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.
Leonard L Gunderson; Michael G Haddock; Robert J Mayer; Jennifer Moughan; John E Pedersen; Tyvin A Rich; Charles R Thomas; Jaffer A Ajani; Al B Benson; Kathryn A Winter; Christopher G Willett
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Jeffrey A Meyerhardt; Rex B Mowat; Donna Niedzwiecki; Leonard B Saltz; Kaori Sato; Alan P Venook; Renaud Whittom; Devin S Wigler; Cynthia Ye; Al Benson; Alexander Hantel; Robert J Mayer; Charles S Fuchs
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Mayer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer A Chan; Nadine Jackson; Paige Malinowski; Robert J Mayer; Eileen Regan; Matthew H Kulke
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.
Cancer chemotherapy and pharmacology 2013;71(5):1241-6.
2012: Leonard L Gunderson; Michael G Haddock; Robert J Mayer; Jennifer Moughan; John E Pedersen; Tyvin A Rich; Charles R Thomas; Jaffer A Ajani; Al B Benson; Kathryn A Winter; Christopher G Willett
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4344-51.
2012: Jeffrey A Meyerhardt; Rex B Mowat; Donna Niedzwiecki; Leonard B Saltz; Kaori Sato; Alan P Venook; Renaud Whittom; Devin S Wigler; Cynthia Ye; Al Benson; Alexander Hantel; Robert J Mayer; Charles S Fuchs
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of the National Cancer Institute 2012;104(22):1702-11.
2012: Robert J Mayer
Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(27):3325-7.
2012: Shuji Ogino; Leonard B Saltz; Paul Schaefer; Kaori Shima; Donna Spiegelman; Renaud Whittom; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Nadine J McCleary; Jeffrey A Meyerhardt; Kimmie Ng; Al B Benson; Monica M Bertagnolli; Charles S Fuchs
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):890-900.
2011: Kimmie Ng; Donna Niedzwiecki; Shuji Ogino; Leonard B Saltz; Paul L Schaefer; Alan P Venook; Renaud Whittom; Al B Benson; Monica M Bertagnolli; Andrew T Chan; Jennifer A Chan; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Jeffrey A Meyerhardt; Charles S Fuchs
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Journal of the National Cancer Institute 2011;103(20):1540-51.
2011: Monica M Bertagnolli; Thomas A Colacchio; Carolyn Corlies Compton; Richard M Goldberg; Robert J Mayer; Donna Niedzwiecki; Mark Redston; Leonard B Saltz; Robert S Warren
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3153-62.
2011: Donna Niedzwiecki; Mark O'Rourke; Michael C Perry; J Marc Pipas; Gity N Porjosh; Philippe Rougier; Joel H Schwartz; Robert S Warren; Steven Alberts; James Atkins; Al Bowen Benson; Monica M Bertagnolli; Carolyn Corlies Compton; S Gail Eckhardt; Anthony Fields; Richard M Goldberg; Nancy E Kemeny; David J Kerr; Robert J Mayer; Thomas A Colacchio
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3146-52.
2010: Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Charlie S Fuchs
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4354-63.
2010: Jennifer King; Theodore S Lawrence; Sharon B Murphy; Nancy E Davidson; Robert J Mayer
The American Society of Clinical Oncology Cancer Foundation Grants Program: a 25-year report and a look toward the future.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1616-21.
2009: Shuji Ogino; Jeffrey A Meyerhardt; Natsumi Irahara; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al B Benson; Richard M Goldberg; Monica M Bertagnolli; Charlie S Fuchs
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7322-9.
2009: Matthew H Kulke; Margaret A Tempero; Donna Niedzwiecki; Donna R Hollis; Hedy L Kindler; Michael Cusnir; Peter C Enzinger; Stefan M Gorsch; Richard M Goldberg; Robert J Mayer
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5506-12.
2009: Monica M Bertagnolli; Donna Niedzwiecki; Carolyn Corlies Compton; Hejin P Hahn; Margaret Hall; Beatrice Damas; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Robert S Warren; Mark Redston
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1814-21.
2009: Monica M Bertagnolli; Robert S Warren; Donna Niedzwiecki; Elke Mueller; Carolyn Corlies Compton; Mark Redston; Margaret Hall; Hejin P Hahn; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Massimo Loda
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2116-22.
2009: Peter C Enzinger; David P Ryan; jeffrey clark; Alona Muzikansky; Craig C Earle; Matthew H Kulke; Jeffrey A Meyerhardt; Lawrence S Blaszkowsky; Andrew X Zhu; Panos Fidias; Michele Vincitore; Robert J Mayer; Charlie S Fuchs
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(3):475-80.
2008: Andreas Neubauer; Kati Maharry; Krzysztof Mrózek; Christian Thiede; Guido Marcucci; Peter Paschka; Robert J Mayer; Richard A Larson; Edison Liu; Clara D Bloomfield
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4603-9.
2008: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4109-15.
2008: Neal J Meropol; Donna Niedzwiecki; Brenda Shank; Thomas A Colacchio; John Ellerton; Frank Valone; Susan Budinger; Jeannette M Day; Judy Hopkins; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3229-34.
2008: Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charlie S Fuchs
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2008;299(21):2515-23.
2007: Jeffrey A Meyerhardt; jeffrey clark; Jeffrey G Supko; Joseph P Eder; Shuji Ogino; Clinton F Stewart; Ferdinando D'Amato; Janet Dancey; Peter C Enzinger; Andrew X Zhu; David P Ryan; Craig C Earle; Robert J Mayer; Ann Michelini; Kate Kinsella; Charlie S Fuchs
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.
Cancer chemotherapy and pharmacology 2007;60(5):661-70.
2007: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Frank B Hu; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2007;298(7):754-64.
2007: Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3456-61.
2007: Jeffrey A Meyerhardt; Keith Stuart; Charlie S Fuchs; Andrew X Zhu; Craig C Earle; Pankaj Bhargava; Lawrence S Blaszkowsky; Peter C Enzinger; Robert J Mayer; S Battu; C Lawrence; David P Ryan
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1185-9.
2007: Brian M Wolpin; Jeffrey A Meyerhardt; Harvey J Mamon; Robert J Mayer
Adjuvant treatment of colorectal cancer.
CA: a cancer journal for clinicians 2007;57(3):168-85.
2007: Ajay Goel; Takeshi Nagasaka; Christian N Arnold; Toru Inoue; Cody Hamilton; Donna Niedzwiecki; Carolyn Corlies Compton; Robert J Mayer; Richard M Goldberg; Monica M Bertagnolli; C Richard Boland
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Gastroenterology 2007;132(1):127-38.
2006: Wolfram Goessling; Robert J Mayer
Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.
Gastroenterology clinics of North America 2006;35(3):713-27.
2006: Steven R Smalley; Jacqueline K Benedetti; Stephen K Williamson; John M Robertson; Norman C. Estes; Tracy Maher; Bernard Fisher; tyvin rich; James A Martenson; John W Kugler; Al B Benson; Daniel G Haller; Robert J Mayer; James N Atkins; Christine Cripps; John Pedersen; Phillip O Periman; Michael S Tanaka; Cynthia G Leichman; John S Macdonald
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3542-7.
2006: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charlie S Fuchs
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3535-41.
2006: Sherif S Farag; Kellie J Archer; Krzysztof Mrózek; Amy S Ruppert; Andrew J Carroll; James W Vardiman; Mark J Pettenati; Maria R Baer; Mazin B Qumsiyeh; Prasad R K Koduru; Yi Ning; Robert J Mayer; Richard M Stone; Richard A Larson; Clara D Bloomfield
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Blood 2006;108(1):63-73.
2006: Richard M Goldberg; Donna Niedzwiecki; Monica M Bertagnolli; A. William Blackstock; Joel E Tepper; Robert J Mayer
Cancer and leukemia group B gastrointestinal cancer committee.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3589s-95s.
2006: David P Ryan; Donna Niedzwiecki; Donna Hollis; Brent E Mediema; Scott Wadler; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2557-62.
2006: Bernard Levin; James S Barthel; Randall W Burt; Donald S David; James M Ford; Francis M Giardiello; Stephen B Gruber; Amy L Halverson; Stanley Hamilton; Wendy Kohlmann; Kirk A Ludwig; Patrick M Lynch; Christopher Marino; Edward W Martin; Robert J Mayer; Boris Pasche; Samuel J Pirruccello; Ashwani Rajput; M Sambasiva Rao; Moshe Shike; Gideon Steinbach; Jonathan P Terdiman; David Weinberg; Sidney J Winawer
Colorectal Cancer Screening Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):384-420.
2006: Nancy Kemeny; Donna Niedzwiecki; Donna Hollis; Heinz-Josef Lenz; Robert S Warren; Michelle J Naughton; Jane C Weeks; Elin R Sigurdson; James E Herndon; Chunfeng Zhang; Robert J Mayer
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1395-403.
2006: Mark Redston; Carolyn Corlies Compton; Brent W Miedema; Donna Niedzwiecki; Jeannette M Dowell; Scott D Jewell; James M Fleshman; Jiri Bem; Robert J Mayer; Monica M Bertagnolli
Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):878-83.
2006: Roy S Herbst; Dean F Bajorin; Harry Bleiberg; Diane Blum; Desirée Hao; Bruce E Johnson; Robert F Ozols; George D Demetri; Patricia Anne Ganz; Mark G Kris; Bernard Levin; Maurie Markman; Derek Raghavan; Gregory H Reaman; Raymond Sawaya; Lynn Schuchter; John W Sweetenham; Linda Vahdat; Everett E Vokes; Rodger J Winn; Robert J Mayer
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):190-205.
2005: Peter C Enzinger; Matthew H Kulke; jeffrey clark; David P Ryan; Haesook T Kim; Craig C Earle; Michele Vincitore; Ann Michelini; Robert J Mayer; Charlie S Fuchs
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma.
Digestive diseases and sciences 2005;50(12):2218-23.
2005: Adam C Berger; Elin R Sigurdson; Thomas LeVoyer; Alexandra Hanlon; Robert J Mayer; John S MacDonald; Paul J Catalano; Daniel G Haller
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8706-12.
2005: Guido Marcucci; Krzysztof Mrózek; Amy S Ruppert; Kati Maharry; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Mark J Pettenati; Bayard L Powell; Colin G Edwards; Lisa J Sterling; James W Vardiman; Charles Alan Schiffer; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5705-17.
2005: Elizabeth A Poplin; Jacqueline K Benedetti; Norman C. Estes; Daniel G Haller; Robert J Mayer; Richard M Goldberg; Geoffrey R Weiss; Saul E Rivkin; John S Macdonald
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1819-25.
2005: Jeffrey A Meyerhardt; Robert J Mayer
Systemic therapy for colorectal cancer.
The New England journal of medicine 2005;352(5):476-87.
2005: Sherif S Farag; Amy S Ruppert; Krzysztof Mrózek; Robert J Mayer; Richard M Stone; Andrew J Carroll; Bayard L Powell; Joseph O Moore; Mark J Pettenati; Prasad R K Koduru; Judith Stamberg; Maria R Baer; AnneMarie W Block; James W Vardiman; Jonathan E Kolitz; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):482-93.
2004: Ajay Goel; Christian N Arnold; Pierfrancesco Tassone; Dong K Chang; Donna Niedzwiecki; Jeannette M Dowell; Linda Wasserman; Carolyn Corlies Compton; Robert J Mayer; Monica M Bertagnolli; C Richard Boland
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
International journal of cancer. Journal international du cancer 2004;112(5):754-9.
2004: A David McCollum; Matthew H Kulke; David P Ryan; jeffrey clark; Larry N Shulman; Robert J Mayer; Sylvia Bartel; Charlie S Fuchs
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
American journal of clinical oncology 2004;27(5):485-8.
2004: Christian N Arnold; Ajay Goel; Donna Niedzwiecki; Jeannette M Dowell; Linda Wasserman; Carolyn Corlies Compton; Robert J Mayer; Monica M Bertagnolli; C Richard Boland
APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.
Cancer biology & therapy 2004;3(10):960-4.
2004: Robert J Mayer
Two steps forward in the treatment of colorectal cancer.
The New England journal of medicine 2004;350(23):2406-8.
2004: Mikkael A Sekeres; Bercedis Peterson; Richard K Dodge; Robert J Mayer; Joseph O Moore; Edward J Lee; Jonathan E Kolitz; Maria R Baer; Charles Alan Schiffer; Andrew J Carroll; James W Vardiman; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Richard M Stone
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood 2004;103(11):4036-42.
2004: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Norman Wolmark; Michael J O'Connell; Mirsada Begovic; Cristine Allmer; Linda H Colangelo; Steven R Smalley; Daniel G Haller; James A Martenson; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Christopher G Willett; Richard M Goldberg
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1785-96.
2004: Ajay Goel; Christian N Arnold; Donna Niedzwiecki; John M Carethers; Jeannette M Dowell; Linda Wasserman; Carolyn Corlies Compton; Robert J Mayer; Monica M Bertagnolli; C Richard Boland
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.
Cancer research 2004;64(9):3014-21.
2004: Peter C Enzinger; Robert J Mayer
Gastrointestinal cancer in older patients.
Seminars in oncology 2004;31(2):206-19.
2004: Leonard B Saltz; Neal J Meropol; Patrick J Loehrer; Michael Neil Needle; Justin Kopit; Robert J Mayer
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1201-8.
2004: John C Byrd; Amy S Ruppert; Krzysztof Mrózek; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Judith Stamberg; Prasad R K Koduru; Joseph O Moore; Robert J Mayer; Frederick R Davey; Richard A Larson; Clara D Bloomfield
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1087-94.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):648-57.
2004: Matthew H Kulke; Haesook T Kim; Keith Stuart; jeffrey clark; David P Ryan; Michele Vincitore; Robert J Mayer; Charlie S Fuchs
A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Cancer investigation 2004;22(3):353-9.
2004: Clara D Bloomfield; Amy S Ruppert; Krzysztof Mrózek; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Colin G Edwards; Lisa J Sterling; James W Vardiman; Andrew J Carroll; Mark J Pettenati; Judith Stamberg; John C Byrd; Guido Marcucci; Richard A Larson
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Annals of hematology 2004;83 Suppl 1():S84-5.
2004: Christian N Arnold; Ajay Goel; Carolyn Corlies Compton; Victoria Marcus; Donna Niedzwiecki; Jeannette M Dowell; Linda Wasserman; Toru Inoue; Robert J Mayer; Monica M Bertagnolli; C Richard Boland
Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
Cancer biology & therapy 2004;3(1):73-8.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; Deborah Schrag; John Z Ayanian; Michael J O'Connell; Jane C Weeks; Robert J Mayer; Christopher G Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):166-74.
2003: Peter C Enzinger; Robert J Mayer
Esophageal cancer.
The New England journal of medicine 2003;349(23):2241-52.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Deborah Schrag; John Z Ayanian; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
Annals of internal medicine 2003;139(8):649-57.
2003: Joel E Tepper; M O'Connell; Donna Hollis; Donna Niedzwiecki; E Cooke; Robert J Mayer
Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3623-8.
2003: TE Le Voyer; Elin R Sigurdson; Alexandra L Hanlon; Robert J Mayer; John S MacDonald; Paul J Catalano; Daniel G Haller
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2912-9.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Daniel G Haller; Robert J Mayer; Al B Benson; John S Macdonald; Charlie S Fuchs
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Cancer 2003;98(3):484-95.
2003: Jeffrey A Meyerhardt; Robert J Mayer
Follow-up strategies after curative resection of colorectal cancer.
Seminars in oncology 2003;30(3):349-60.
2003: Natalie E Joseph; Elin R Sigurdson; Alexandra L Hanlon; Hao Wang; Robert J Mayer; John S MacDonald; Paul J Catalano; Daniel G Haller
Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection.
Annals of surgical oncology 2003;10(3):213-8.
2003: Ajay Goel; Christian N Arnold; Donna Niedzwiecki; Dong K Chang; Luigi Ricciardiello; John M Carethers; Jeannette M Dowell; Linda Wasserman; Carolyn Corlies Compton; Robert J Mayer; Monica M Bertagnolli; C Richard Boland
Characterization of sporadic colon cancer by patterns of genomic instability.
Cancer research 2003;63(7):1608-14.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):433-40.
2003: A. William Blackstock; Joel E Tepper; Donna Niedwiecki; Donna Hollis; Robert J Mayer; Margaret A Tempero
Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.
International journal of gastrointestinal cancer 2003;34(2-3):107-16.
2003: David P Ryan; jeffrey clark; Matthew H Kulke; Charlie S Fuchs; Craig C Earle; Peter C Enzinger; Keith Stuart; Keith J Catarius; Jennifer Winkelmann; Robert J Mayer
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.
Cancer investigation 2003;21(4):505-11.
2002: John C Byrd; Krzysztof Mrózek; Richard K Dodge; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Shivanand R Patil; Kathleen W Rao; Michael S Watson; Prasad R K Koduru; Joseph O Moore; Richard M Stone; Robert J Mayer; Eric J Feldman; Frederick R Davey; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
Blood 2002;100(13):4325-36.
2002: Sherif S Farag; Kellie J Archer; Krzysztof Mrózek; James W Vardiman; Andrew J Carroll; Mark J Pettenati; Joseph O Moore; Jonathan E Kolitz; Robert J Mayer; Richard M Stone; Richard A Larson; Clara D Bloomfield
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
International journal of oncology 2002;21(5):1041-51.
2002: Robert C Miller; Daniel J Sargent; James A Martenson; John S Macdonald; Daniel Haller; Robert J Mayer; Leonard L Gunderson; tyvin rich; Stephen S Cha; Michael J O'Connell
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.
International journal of radiation oncology, biology, physics 2002;54(2):409-13.
2002: Leonard L Gunderson; Daniel J Sargent; Joel E Tepper; Michael J O'Connell; Cristine Allmer; Steven R Smalley; James A Martenson; Daniel G Haller; Robert J Mayer; tyvin rich; Jaffer A Ajani; John S Macdonald; Richard M Goldberg
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
International journal of radiation oncology, biology, physics 2002;54(2):386-96.
2002: Matthew H Kulke; George D Demetri; Norman E Sharpless; David P Ryan; Ramesh A Shivdasani; Jeffrey S Clark; Bruce M Spiegelman; Haesook T Kim; Robert J Mayer; Charlie S Fuchs
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.
Cancer journal (Sudbury, Mass.) 2002;8(5):395-9.
2002: A David McCollum; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
Journal of the National Cancer Institute 2002;94(15):1160-7.
2002: Charlie S Fuchs; jeffrey clark; David P Ryan; Matthew H Kulke; Haesook T Kim; Craig C Earle; Michele Vincitore; Robert J Mayer; Keith E Stuart
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.
Cancer 2002;94(12):3186-91.
2002: Joel E Tepper; M O'Connell; Donna Niedzwiecki; Donna Hollis; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; James A Martenson; Robert J Mayer
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1744-50.
2002: Robert J Green; Joshua P Metlay; Kathleen J Propert; Paul J Catalano; John S Macdonald; Robert J Mayer; Daniel G Haller
Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089.
Annals of internal medicine 2002;136(4):261-9.
2002: Wolfram Goessling; Phillip H McKee; Robert J Mayer
Merkel cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):588-98.
2002: David P Ryan; Matthew H Kulke; Charlie S Fuchs; Michael L Grossbard; Steven R Grossman; Jeffrey A Morgan; Craig C Earle; Ramesh A Shivdasani; Haesook T Kim; Robert J Mayer; jeffrey clark
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
Cancer 2002;94(1):97-103.
2001: Peter J O'Dwyer; J Manola; F H Valone; L M Ryan; J D Hines; S Wadler; Daniel G Haller; Arbuck Susan; L M Weiner; Robert J Mayer; Al B Benson
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2413-21.
2001: Mark J Krasna; Carolyn E Reed; D Nedzwiecki; D R Hollis; J D Luketich; M M DeCamp; Robert J Mayer; David J Sugarbaker
CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer.
The Annals of thoracic surgery 2001;71(4):1073-9.
2001: Neal J Meropol; Donna Niedzwiecki; D Hollis; R L Schilsky; Robert J Mayer
Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.
Cancer 2001;91(7):1256-63.
2001: Craig C Earle; W Y Chen; D P Ryan; Robert J Mayer
Oxaliplatin-induced Evan's syndrome.
British journal of cancer 2001;84(3):441.
2001: Robert J Mayer
Efficacy of neo- and adjuvant treatment modalities in gastrointestinal cancer patients.
Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera 2001;7(6):239-42.
2001: Joel E Tepper; Michael J O'Connell; Donna Niedzwiecki; Donna Hollis; Carolyn Corlies Compton; Al B Benson; Bernard Cummings; Leonard L Gunderson; John S Macdonald; Robert J Mayer
Impact of number of nodes retrieved on outcome in patients with rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):157-63.
2000: Ian Krop; Tad J Wieczorek; Robert J Mayer
Diagnostic dilemmas in oncology. Case 3. Metastatic ovarian cancer simulating colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3189-92.
2000: David P Ryan; Robert J Mayer
Anal carcinoma: histology, staging, epidemiology, treatment.
Current opinion in oncology 2000;12(4):345-52.
2000: Pasi A Janne; Robert J Mayer
Chemoprevention of colorectal cancer.
The New England journal of medicine 2000;342(26):1960-8.
2000: David P Ryan; Carolyn Corlies Compton; Robert J Mayer
Carcinoma of the anal canal.
The New England journal of medicine 2000;342(11):792-800.
2000: D P Ryan; Thomas J Lynch; M L Grossbard; Michael Seiden; Charlie S Fuchs; N Grenon; P Baccala; D Berg; D Finkelstein; Robert J Mayer; jeffrey clark
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.
Cancer 2000;88(1):180-5.
1999: John C Byrd; Richard K Dodge; Andrew J Carroll; Maria R Baer; C Edwards; Judith Stamberg; Mazin B Qumsiyeh; Joseph O Moore; Robert J Mayer; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3767-75.
1999: Matthew H Kulke; Robert J Mayer
Carcinoid tumors.
The New England journal of medicine 1999;340(11):858-68.
1999: Robert J Mayer
Third International Conference on Biology, Prevention and Treatment of Gastrointestinal Malignancies. Cologne, 23-26 September 1998.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):281-7.
1998: Clara D Bloomfield; David S Lawrence; John C Byrd; Andrew J Carroll; Mark J Pettenati; Ramana Tantravahi; Shivanand R Patil; Frederick R Davey; D T Berg; Charles Alan Schiffer; Diane C Arthur; Robert J Mayer
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Cancer research 1998;58(18):4173-9.
1998: Robert J Mayer
The state of the society: a year of continued growth.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3192-8.
1998: Alice B Kornblith; James E Herndon; Enid Zuckerman; David Cella; E Cherin; S Wolchok; Raymond B Weiss; L F Diehl; E Henderson; M Robert Cooper; Charles Alan Schiffer; George P Canellos; Robert J Mayer; R T Silver; A Schilling; Bruce A Peterson; D Greenberg; Jimmie C Holland
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):297-306.
1997: Krzysztof Mrózek; K Heinonen; David S Lawrence; Andrew J Carroll; Prasad R K Koduru; Kathleen W Rao; Matthew P Strout; R E Hutchison; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.
Blood 1997;90(11):4532-8.
1997: Donna B Greenberg; Alice B Kornblith; James E Herndon; Enid Zuckerman; Charles Alan Schiffer; Raymond B Weiss; Robert J Mayer; S M Wolchok; Jimmie C Holland
Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress.
Cancer 1997;80(10):1936-44.
1997: James L Slack; Diane C Arthur; David S Lawrence; Krzysztof Mrózek; Robert J Mayer; Frederick R Davey; Ramana Tantravahi; Mark J Pettenati; S Bigner; Andrew J Carroll; Kathleen W Rao; Charles Alan Schiffer; Clara D Bloomfield
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1786-95.
1997: John C Byrd; R B Weiss; Diane C Arthur; David S Lawrence; Maria R Baer; Frederick R Davey; E S Trikha; Andrew J Carroll; Ramana Tantravahi; Mazin B Qumsiyeh; Shivanand R Patil; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):466-75.
1997: Sidney J Winawer; Robert Fletcher; L Miller; F Godlee; M H Stolar; Cynthia Mulrow; S H Woolf; S N Glick; T G Ganiats; John H Bond; L Rosen; Jane G Zapka; S J Olsen; Francis M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; Robert J Mayer
Colorectal cancer screening: clinical guidelines and rationale.
Gastroenterology 1997;112(2):594-642.
1996: Steven H Bernstein; V L Brunetto; Frederick R Davey; D Wurster-Hill; Robert J Mayer; Richard M Stone; Charles Alan Schiffer; Clara D Bloomfield
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2486-94.
1995: Charlie S Fuchs; Robert J Mayer
Adjuvant chemotherapy for colon and rectal cancer.
Seminars in oncology 1995;22(5):472-87.
1995: Robert J Mayer
Summary of the Second International Conference on Biology, Prevention and Treatment of Gastrointestinal Malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(7):645-9.
1995: Charlie S Fuchs; Robert J Mayer
Gastric carcinoma.
The New England journal of medicine 1995;333(1):32-41.
1995: Frederick R Davey; N Abraham; V L Brunetto; J M MacCallum; D A Nelson; E D Ball; James D Griffin; Maria R Baer; D Wurster-Hill; Robert J Mayer
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
American journal of hematology 1995;49(1):29-38.
1994: Robert J Mayer; R B Davis; Charles Alan Schiffer; D T Berg; B L Powell; P Schulman; G A Omura; J O Moore; O R McIntyre; Emil Frei
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
The New England journal of medicine 1994;331(14):896-903.
1994: Marshall R Posner; Robert J Mayer
The use of serologic tumor markers in gastrointestinal malignancies.
Hematology/oncology clinics of North America 1994;8(3):533-53.
1993: H A Fine; Robert J Mayer
Primary central nervous system lymphoma.
Annals of internal medicine 1993;119(11):1093-104.
1993: Robert J Mayer
Overview: the changing nature of esophageal cancer.
Chest 1993;103(4 Suppl):404S-405S.
1993: Richard M Stone; David Spriggs; K A Arthur; Robert J Mayer; James D Griffin; Donald Kufe
Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes.
American journal of clinical oncology 1993;16(2):159-63.
1993: Richard M Stone; Robert J Mayer
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
Hematology/oncology clinics of North America 1993;7(1):47-64.
1993: Richard M Stone; Robert J Mayer
The approach to the elderly patient with acute myeloid leukemia.
Hematology/oncology clinics of North America 1993;7(1):65-79.
1992: Robert J Mayer
Chemotherapy for metastatic colorectal cancer.
Cancer 1992;70(5 Suppl):1414-24.
1992: E H Rubin; J W Andersen; D T Berg; Charles Alan Schiffer; Robert J Mayer; Richard M Stone
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):948-53.
1992: A Lerner; R Gonin; Glenn Steele; Robert J Mayer
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):536-40.
1991: James A DeCaprio; Robert J Mayer; R Gonin; Arbuck Susan
Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2128-33.
1991: Robert J Mayer
Systemic therapy for colorectal cancer: an overview.
Seminars in oncology 1991;18(5 Suppl 7):62-6.
1991: Stephen A Cannistra; J DiCarlo; P Groshek; Y Kanakura; D Berg; Robert J Mayer; James D Griffin
Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
Leukemia 1991;5(3):230-8.
1990: Richard M Stone; David Spriggs; R K Dhawan; K A Arthur; Robert J Mayer; Donald Kufe
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.
Leukemia 1990;4(12):843-7.
1990: Richard M Stone; Robert J Mayer
The unique aspects of acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1913-21.
1990: Robert J Mayer
Intensive chemotherapy versus allogeneic bone marrow transplantation in first-remission acute myeloid leukemia.
Bone marrow transplantation 1990;6 Suppl 1():48-51.
1990: Robert J Mayer
Acute leukemias in adults: an overview of recent strategies.
Journal of cancer research and clinical oncology 1990;116(1):94-6.
1989: M A Caligiuri; Robert J Mayer
Pregnancy and leukemia.
Seminars in oncology 1989;16(5):388-96.
1989: Robert J Mayer; M J O'Connell; Joel E Tepper; N Wolmark
Status of adjuvant therapy for colorectal cancer.
Journal of the National Cancer Institute 1989;81(18):1359-64.
1989: Frederick R Davey; R B Davis; J M MacCallum; D A Nelson; Robert J Mayer; E D Ball; James D Griffin; Charles Alan Schiffer; Clara D Bloomfield
Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
American journal of hematology 1989;30(4):221-7.
1988: James A Talcott; R Finberg; Robert J Mayer; L Goldman
The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation.
Archives of internal medicine 1988;148(12):2561-8.
1988: Robert J Mayer
Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a "best choice"?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1532-6.
1988: David Spriggs; Gregory Robbins; K Arthur; Robert J Mayer; Donald Kufe
Prolonged high dose ARA-C infusions in acute leukemia.
Leukemia 1988;2(5):304-6.
1988: D A Haber; Robert J Mayer
Primary gastrointestinal lymphoma.
Seminars in oncology 1988;15(2):154-69.
1988: Richard M Stone; M Maguire; M A Goldberg; Joseph H Antin; D S Rosenthal; Robert J Mayer
Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Blood 1988;71(3):690-6.
1987: Robert J Mayer
Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.
Seminars in oncology 1987;14(4):384-96.